Cited by 252Amyotrophic Lateral Sclerosis ResearchNeurogenetic and Muscular Disorders ResearchMuscle Physiology and Disorders

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Sexual differences in onset of disease and response to exercise in a transgenic model of ALS

Abstract

Transgenic mice that overexpress the mutant human SOD1 gene (hSOD1) serve as an animal model for amyotrophic lateral sclerosis (ALS). Age and sex are recognized as risk factors for ALS, but physical activity remains controversial. Therefore, we investigated the effect of exercise on the phenotype of male and female hSOD1 mice. Onset of disease, progression of disease and survival were measured in low-copy and high-copy hSOD1 mice that were randomized to an exercise or sedentary group. We found that onset of disease was different for the two sexes: significantly earlier in male than in female hSOD1 mice. Exercise delayed the onset of disease in female but not in male hSOD1 mice. Also, exercise delayed the total survival time in female high-copy hSOD1 mice. Muscle morphometry and motor neuron counts were similar in all experimental groups at the end of training. Sedentary female hSOD1 mice showed more frequently irregular estrous cycles suggesting a higher estrogen exposure in exercising female mice. These results suggest a possible neuroprotective effect of female sex hormones and support the view that ALS patients should not avoid regular exercise.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0960-8966(03)00104-4

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Studies in transgenic mice overexpressing mutant SOD1 gave contradictory findings on exercise.

    “In addition, studies performed on transgenic mice overexpressing the mutant superoxide dismutase gene 1 (SOD1)-the animal model for ALS-gave contradictory findings (Veldink et al., 2003;Mahoney et al., 2004).”

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 28

  1. Haverkamp, 1995, Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction, Brain, 118, 707, 10.1093/brain/118.3.707 · DOI
  2. Rowland, 1998, What's in a name? Amyotrophic lateral sclerosis, motor neuron disease, and allelic heterogeneity, Ann Neurol, 43, 691, 10.1002/ana.410430602 · DOI
  3. Shaw, 1997, Familial amyotrophic lateral sclerosis. Molecular pathology of a patient with a SOD1 mutation, Neurology, 49, 1612, 10.1212/WNL.49.6.1612 · DOI
  4. Orrell, 2000, Amyotrophic lateral sclerosis: Copper/zinc superoxide dismutase (SOD1) gene mutations, Neuromus Disord, 10, 63, 10.1016/S0960-8966(99)00071-1 · DOI
  5. Gurney, 1994, Motor neuron degeneration in mice that express a human CuZn superoxide dismutase mutation, Science, 264, 1772, 10.1126/science.8209258 · DOI · Paper page
  6. Traynor, 1999, Incidence and prevalence of ALS in Ireland, 1995–1997: a population-based study, Neurology, 52, 504, 10.1212/WNL.52.3.504 · DOI · Paper page
  7. Chio, 1991, Risk factors in motor neuron disease: a case-control study, Neuroepidemiology, 10, 174, 10.1159/000110267 · DOI
  8. Scarmeas, 2002, Premorbid weight, body mass, and varsity athletics in ALS, Neurology, 59, 773, 10.1212/WNL.59.5.773 · DOI · Paper page
  9. Longstreth, 1998, Risk of amyotrophic lateral sclerosis and history of physical activity: a population-based case-control study, Arch Neurol, 55, 201, 10.1001/archneur.55.2.201 · DOI
  10. Sjodin, 1990, Biochemical mechanisms for oxygen free radical formation during exercise, Sports Med, 10, 236, 10.2165/00007256-199010040-00003 · DOI
  11. Bär, 1997, Protection against muscle damage exerted by oestrogen: hormonal or antioxidant action?, Biochem Soc Trans, 25, 50, 10.1042/bst0250050 · DOI
  12. Barneoud, 1997, Quantitative motor assessment in FALS mice: a longitudinal study, Neuroreport, 8, 2861, 10.1097/00001756-199709080-00012 · DOI
  13. Fernando, 1993, Predicting submaximal oxygen consumption during treadmill running in mice, Can J Physiol Pharmacol, 71, 854, 10.1139/y93-128 · DOI
  14. Gurney, 1996, Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis, Ann Neurol, 39, 147, 10.1002/ana.410390203 · DOI
  15. Kong, 1998, Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1, J Neurosci, 18, 3241, 10.1523/JNEUROSCI.18-09-03241.1998 · DOI
  16. Adams, 1981, Heavy metal intensification of DAB-based HRP reaction product, J Histochem Cytochem, 29, 775, 10.1177/29.6.7252134 · DOI
  17. Szymczak, 1998, Concentration of sex steroids in adipose tissue after menopause, Steroids, 63, 319, 10.1016/S0039-128X(98)00019-1 · DOI
  18. Carlberg, 1985, Disruption of estrous cycles in exercise-trained rats, Proc Soc Exp Biol Med, 179, 21, 10.3181/00379727-179-42058 · DOI
  19. Mukherjee, 1994, Functional relevance of luteinizing hormone receptor in mouse uterus, Eur J Endocrinol, 131, 103, 10.1530/eje.0.1310103 · DOI
  20. Brooks, 1994, El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis, J Neurol Sci, 124, 96, 10.1016/0022-510X(94)90191-0 · DOI
  21. Armon, 2001, Environmental risk factors for amyotrophic lateral sclerosis, Neuroepidemiology, 20, 2, 10.1159/000054751 · DOI
  22. Brooks, 2000, Risk factors in the early diagnosis of ALS: North American epidemiological studies. ALS CARE Study Group, Amyotroph Lateral Scler Other Motor Neuron Disord, 1, S19, 10.1080/14660820052415871 · DOI
  23. Drory, 2001, The value of muscle exercise in patients with amyotrophic lateral sclerosis, J Neurol Sci, 191, 133, 10.1016/S0022-510X(01)00610-4 · DOI
  24. Pinto, 1999, Can amyotrophic lateral sclerosis patients with respiratory insufficiency exercise?, J Neurol Sci, 169, 69, 10.1016/S0022-510X(99)00218-X · DOI
  25. Behl, 2002, Oestrogen as a neuroprotective hormone, Nat Rev Neurosci, 3, 433, 10.1038/nrn846 · DOI
  26. De Cree, 1998, Sex steroid metabolism and menstrual irregularities in the exercising female. A review, Sports Med, 25, 369, 10.2165/00007256-199825060-00003 · DOI
  27. Nakamizo, 2000, Protection of cultured spinal motor neurons by estradiol, Neuroreport, 11, 3493, 10.1097/00001756-200011090-00019 · DOI
  28. Frey, 2000, Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases, J Neurosci, 20, 2534, 10.1523/JNEUROSCI.20-07-02534.2000 · DOI

Cited by

Sorted by citations

Metadata

Authors
Veldink, J. H., Bär, P. R., Joosten, E. A. J., Otten, M., Wokke, J. H. J., & van den Berg, L. H.
Affiliations
University Medical Center Utrecht (NL)
Corresponding author
van den Berg, L.H.
Venue
Neuromuscular Disorders
Publisher
Elsevier BV
Published
2003-11
Volume
13
Issue
9
Pages
737-743
ISSN
0960-8966 (ISSN-L)
OpenAlex
W1997874493
Cited by
252
References
1
Citations by year
2026: 5 · 2025: 4 · 2024: 16 · 2023: 6 · 2022: 8 · 2021: 11 · 2020: 8 · 2019: 8 · 2018: 13 · 2017: 11 · 2016: 8 · 2015: 11 · 2014: 13 · 2013: 13 · 2012: 8
FWCI
7.77
Type
journal article
Language
en
Open access
closed
Locations
  • Neuromuscular Disorders (publishedVersion)
  • PubMed (publishedVersion)
Funders
Koninklijke Nederlandse Akademie van Wetenschappen
Topics
  • Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
  • Health Sciences › Medicine › Genetics (clinical) › Neurogenetic and Muscular Disorders Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
Keywords
amyotrophic lateral sclerosis, SOD1 transgenic mice, sex differences, physical activity, disease onset, survival, estrogen, estrous cycle, neuroprotection, motor neuron degeneration
MeSH terms
Age Factors, Amyotrophic Lateral Sclerosis, Animals, Cell Count, Choline O-Acetyltransferase, Disease Models, Animal, Estrogens, Female, Humans, Immunohistochemistry, Male, Mice, Transgenic, Motor Neurons, Physical Conditioning, Animal, Random Allocation, Risk Factors, Sex Characteristics, Spinal Cord, Superoxide Dismutase, Time Factors, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review